{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T01:56:20Z","timestamp":1777773380308,"version":"3.51.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the National Natural Science Foundation incubation project of The Second Affiliated Hospital of Nanchang University","award":["2023YNFY12031"],"award-info":[{"award-number":["2023YNFY12031"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82060435"],"award-info":[{"award-number":["82060435"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Project of the Jiangxi Provincial Department of Science and Technology","award":["20202BAB206052"],"award-info":[{"award-number":["20202BAB206052"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-85737-1","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T06:28:58Z","timestamp":1736317738000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["hsa_circ_0008305 facilitates the malignant progression of hepatocellular carcinoma by regulating AKR1C3 expression and sponging miR-379-5p"],"prefix":"10.1038","volume":"15","author":[{"given":"Shenglan","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongkan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shumin","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianbing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,8]]},"reference":[{"issue":"1","key":"85737_CR1","first-page":"7","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel, R. L., Miller, K. D., Fuchs, H. E. & Jemal, A. Cancer statistics, 2022. CA Cancer J. Clin. 72 (1), 7\u201333 (2022).","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"85737_CR2","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71 (3), 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"issue":"10","key":"85737_CR3","first-page":"2020","volume":"19","author":"ND Parikh","year":"2021","unstructured":"Parikh, N. D. & Pillai, A. Recent advances in hepatocellular carcinoma treatment. Clinical gastroenterology and hepatology: the official clinical practice. J. Am. Gastroenterol. Assoc. 19 (10), 2020\u20132024 (2021).","journal-title":"J. Am. Gastroenterological Association"},{"issue":"1","key":"85737_CR4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13045-024-01535-8","volume":"17","author":"Q Lu","year":"2024","unstructured":"Lu, Q. et al. Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy. J. Hematol. Oncol. 17 (1), 16 (2024).","journal-title":"J. Hematol. Oncol."},{"issue":"12","key":"85737_CR5","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/s41571-023-00825-3","volume":"20","author":"AG Singal","year":"2023","unstructured":"Singal, A. G., Kanwal, F. & Llovet, J. M. Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy. Nat. Rev. Clin. Oncol. 20 (12), 864\u2013884 (2023).","journal-title":"Nat. Reviews Clin. Oncol."},{"issue":"1","key":"85737_CR6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12943-022-01706-6","volume":"22","author":"Y Tian","year":"2023","unstructured":"Tian, Y. et al. Crosstalk between 5-methylcytosine and N(6)-methyladenosine machinery defines disease progression, therapeutic response and pharmacogenomic landscape in hepatocellular carcinoma. Mol. Cancer  22 (1), 5 (2023).","journal-title":"Mol. Cancer"},{"issue":"10","key":"85737_CR7","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","volume":"16","author":"JD Yang","year":"2019","unstructured":"Yang, J. D. et al. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat. Rev. Gastroenterol. Hepatol. 16 (10), 589\u2013604 (2019).","journal-title":"Nat. Reviews Gastroenterol. Hepatol."},{"issue":"1","key":"85737_CR8","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/14737140.2020.1712198","volume":"20","author":"A Casadei-Gardini","year":"2020","unstructured":"Casadei-Gardini, A., Orsi, G., Caputo, F. & Ercolani, G. Developments in predictive biomarkers for hepatocellular carcinoma therapy. Expert Rev. Anticancer Ther. 20 (1), 63\u201374 (2020).","journal-title":"Expert Rev. Anticancer Ther."},{"issue":"4","key":"85737_CR9","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nrm.2015.32","volume":"17","author":"LL Chen","year":"2016","unstructured":"Chen, L. L. The biogenesis and emerging roles of circular RNAs. Nat. Rev. Mol. Cell. Biol. 17 (4), 205\u2013211 (2016).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"issue":"1","key":"85737_CR10","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s13045-021-01145-8","volume":"14","author":"H Shen","year":"2021","unstructured":"Shen, H. et al. Circular RNAs: characteristics, biogenesis, mechanisms and functions in liver cancer. J. Hematol. Oncol. 14 (1), 134 (2021).","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"85737_CR11","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1186\/s12885-018-4689-7","volume":"18","author":"Z Zhang","year":"2018","unstructured":"Zhang, Z. et al. Circular RNA: new star, new hope in cancer. BMC Cancer 18 (1), 834 (2018).","journal-title":"BMC Cancer"},{"issue":"6","key":"85737_CR12","first-page":"1167","volume":"6","author":"F Wang","year":"2016","unstructured":"Wang, F., Nazarali, A. J. & Ji, S. Circular RNAs as potential biomarkers for cancer diagnosis and therapy. Am. J. Cancer Res. 6 (6), 1167\u20131176 (2016).","journal-title":"Am. J. Cancer Res."},{"issue":"1","key":"85737_CR13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12943-023-01759-1","volume":"22","author":"Z Hu","year":"2023","unstructured":"Hu, Z. et al. Exosome-derived circCCAR1 promotes CD8\u2009+\u2009T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma. Mol. Cancer  22 (1), 55 (2023).","journal-title":"Mol. Cancer"},{"issue":"1","key":"85737_CR14","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12943-024-02030-x","volume":"23","author":"XY Zhang","year":"2024","unstructured":"Zhang, X. Y. et al. CircPIAS1 promotes hepatocellular carcinoma progression by inhibiting ferroptosis via the miR-455-3p\/NUPR1\/FTH1 axis. Mol. Cancer  23 (1), 113 (2024).","journal-title":"Mol. Cancer"},{"issue":"1","key":"85737_CR15","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12943-018-0889-7","volume":"17","author":"L Wang","year":"2018","unstructured":"Wang, L. et al. Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-\u03b2-induced epithelial-mesenchymal transition and metastasis by controlling TIF1\u03b3 in non-small cell lung cancer. Mol. Cancer  17 (1), 140 (2018).","journal-title":"Mol. Cancer"},{"issue":"1","key":"85737_CR16","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s12935-021-01985-x","volume":"21","author":"SG Wu","year":"2021","unstructured":"Wu, S. G. et al. circ-PTK2 (hsa_circ_0008305) regulates the pathogenic processes of ovarian cancer via miR-639 and FOXC1 regulatory cascade. Cancer Cell. Int. 21 (1), 277 (2021).","journal-title":"Cancer Cell. Int."},{"key":"85737_CR17","doi-asserted-by":"publisher","first-page":"216023","DOI":"10.1016\/j.canlet.2022.216023","volume":"554","author":"X Meng","year":"2023","unstructured":"Meng, X. et al. CircPTK2\/PABPC1\/SETDB1 axis promotes EMT-mediated tumor metastasis and gemcitabine resistance in bladder cancer. Cancer Lett. 554, 216023 (2023).","journal-title":"Cancer Lett."},{"issue":"4","key":"85737_CR18","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00011-022-01548-4","volume":"71","author":"M Wang","year":"2022","unstructured":"Wang, M., Chen, D., Zhang, H., Luo, C. & Circular, R. N. A. circPTK2 modulates migration and invasion via miR-136\/NFIB signaling on triple-negative breast cancer cells in vitro. Inflamm. Res. Off. J. Eur. Histamine Res. Soc. 71 (4), 409\u2013421 (2022).","journal-title":"Inflamm. Research: Official J. Eur. Histamine Res. Soc. [et al]"},{"issue":"5","key":"85737_CR19","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/nrg.2016.20","volume":"17","author":"DW Thomson","year":"2016","unstructured":"Thomson, D. W. & Dinger, M. E. Endogenous microRNA sponges: evidence and controversy. Nat. Rev. Genet. 17 (5), 272\u2013283 (2016).","journal-title":"Nat. Rev. Genet."},{"issue":"6","key":"85737_CR20","doi-asserted-by":"publisher","first-page":"3502","DOI":"10.3892\/or.2017.5607","volume":"37","author":"D Wu","year":"2017","unstructured":"Wu, D. et al. MicroRNA-379-5p plays a tumor-suppressive role in human bladder cancer growth and metastasis by directly targeting MDM2. Oncol. Rep. 37 (6), 3502\u20133508 (2017).","journal-title":"Oncol. Rep."},{"issue":"4","key":"85737_CR21","first-page":"659","volume":"68","author":"M Liang","year":"2021","unstructured":"Liang, M., Chen, H. & Min, J. Mir-379-5p inhibits proliferation and invasion of the endometrial cancer cells by inhibiting expression of ROR1. Acta Biochim. Pol. 68 (4), 659\u2013665 (2021).","journal-title":"Acta Biochim. Pol."},{"key":"85737_CR22","doi-asserted-by":"crossref","unstructured":"Yang, K. et al. MiR-379-5p inhibits the proliferation, migration, and invasion of breast cancer by targeting KIF4A. Thorac. Cancer (2022).","DOI":"10.1111\/1759-7714.14437"},{"issue":"14","key":"85737_CR23","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.7150\/ijms.74713","volume":"19","author":"Y Zhou","year":"2022","unstructured":"Zhou, Y., Mao, X., Peng, R. & Bai, D. CircRNAs in hepatocellular carcinoma: characteristic, functions and clinical significance. Int. J. Med. Sci. 19 (14), 2033\u20132043 (2022).","journal-title":"Int. J. Med. Sci."},{"key":"85737_CR24","doi-asserted-by":"publisher","first-page":"1093063","DOI":"10.3389\/fonc.2023.1093063","volume":"13","author":"Z Liu","year":"2023","unstructured":"Liu, Z., Yang, F., Xiao, Z. & Liu, Y. Review of novel functions and implications of circular RNAs in hepatocellular carcinoma. Front. Oncol. 13, 1093063 (2023).","journal-title":"Front. Oncol."},{"key":"85737_CR25","doi-asserted-by":"publisher","first-page":"3759879","DOI":"10.1155\/2021\/3759879","volume":"2021","author":"X Bin","year":"2021","unstructured":"Bin, X. et al. circ_0001588 induces the malignant progression of hepatocellular carcinoma by modulating miR-874\/CDK4 signaling. J. Immunol. Res. 2021, 3759879 (2021).","journal-title":"J. Immunol. Res."},{"issue":"5","key":"85737_CR26","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1158\/0008-5472.CAN-20-2480","volume":"81","author":"Q Zhou","year":"2021","unstructured":"Zhou, Q. et al. A positive feedback loop of AKR1C3-mediated activation of NF-\u03baB and STAT3 facilitates proliferation and metastasis in hepatocellular carcinoma. Cancer Res. 81 (5), 1361\u20131374 (2021).","journal-title":"Cancer Res."},{"key":"85737_CR27","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.biopha.2014.12.022","volume":"69","author":"T Zhong","year":"2015","unstructured":"Zhong, T., Xu, F., Xu, J., Liu, L. & Chen, Y. Aldo-keto reductase 1C3 (AKR1C3) is associated with the doxorubicin resistance in human breast cancer via PTEN loss. Biomed. Pharmacother.  69, 317\u2013325 (2015).","journal-title":"Biomed. Pharmacother"},{"issue":"23","key":"85737_CR28","doi-asserted-by":"publisher","first-page":"11471","DOI":"10.1158\/0008-5472.CAN-06-1448","volume":"66","author":"AK Jansson","year":"2006","unstructured":"Jansson, A. K., Gunnarsson, C., Cohen, M., Sivik, T. & St\u00e5l, O. 17beta-hydroxysteroid dehydrogenase 14 affects estradiol levels in breast cancer cells and is a prognostic marker in estrogen receptor-positive breast cancer. Cancer Res. 66 (23), 11471\u201311477 (2006).","journal-title":"Cancer Res."},{"key":"85737_CR29","doi-asserted-by":"crossref","unstructured":"Wang, B. et al. AKR1C3, a crucial androgenic enzyme in prostate cancer, promotes epithelial-mesenchymal transition and metastasis through activating ERK signaling. Urol. Oncol.  36 (10) , 472.e11\u2013e20. (2018).","DOI":"10.1016\/j.urolonc.2018.07.005"},{"issue":"31","key":"85737_CR30","doi-asserted-by":"publisher","first-page":"3846","DOI":"10.1038\/s41388-022-02379-7","volume":"41","author":"D Pan","year":"2022","unstructured":"Pan, D. et al. AKR1C3 regulated by NRF2\/MAFG complex promotes proliferation via stabilizing PARP1 in hepatocellular carcinoma. Oncogene 41 (31), 3846\u20133858 (2022).","journal-title":"Oncogene"},{"issue":"6","key":"85737_CR31","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.4251\/wjgo.v14.i6.1067","volume":"14","author":"ZS Niu","year":"2022","unstructured":"Niu, Z. S. & Wang, W. H. Circular RNAs in hepatocellular carcinoma: recent advances. World J. Gastrointest. Oncol. 14 (6), 1067\u20131085 (2022).","journal-title":"World J. Gastrointest. Oncol."},{"issue":"1","key":"85737_CR32","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12935-020-01703-z","volume":"21","author":"D Cheng","year":"2021","unstructured":"Cheng, D., Wang, J., Dong, Z. & Li, X. Cancer-related circular RNA: diverse biological functions. Cancer Cell. Int. 21 (1), 11 (2021).","journal-title":"Cancer Cell. Int."},{"issue":"9","key":"85737_CR33","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41568-024-00721-7","volume":"24","author":"VM Conn","year":"2024","unstructured":"Conn, V. M., Chinnaiyan, A. M. & Conn, S. J. Circular RNA in cancer. Nat. Rev. Cancer 24 (9), 597\u2013613 (2024).","journal-title":"Nat. Rev. Cancer"},{"issue":"12","key":"85737_CR34","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1016\/j.cell.2022.04.021","volume":"185","author":"CX Liu","year":"2022","unstructured":"Liu, C. X. & Chen, L. L. Circular RNAs: characterization, cellular roles, and applications. Cell 185 (12), 2016\u20132034 (2022).","journal-title":"Cell"},{"key":"85737_CR35","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.bbrc.2021.05.099","volume":"568","author":"B Yang","year":"2021","unstructured":"Yang, B., Xia, S., Ye, X., Jing, W. & Wu, B. MiR-379-5p targets microsomal glutathione transferase 1 (MGST1) to regulate human glioma in cell proliferation, migration and invasion and epithelial-mesenchymal transition (EMT). Biochem. Biophys. Res. Commun. 568, 8\u201314 (2021).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"85737_CR36","doi-asserted-by":"publisher","first-page":"4335","DOI":"10.2147\/CMAR.S253504","volume":"12","author":"F Zhang","year":"2020","unstructured":"Zhang, F., Duan, C., Yin, S. & Tian, Y. MicroRNA-379-5p\/YBX1 Axis regulates cellular EMT to suppress migration and invasion of Nasopharyngeal carcinoma cells. Cancer Manag. Res. 12, 4335\u20134346 (2020).","journal-title":"Cancer Manag Res."},{"issue":"6","key":"85737_CR37","doi-asserted-by":"publisher","first-page":"4499","DOI":"10.3892\/mmr.2020.11553","volume":"22","author":"Y Jiang","year":"2020","unstructured":"Jiang, Y., Zhu, P., Gao, Y. & Wang, A. miR\u2013379\u20135p inhibits cell proliferation and promotes cell apoptosis in non\u2013small cell lung cancer by targeting \u03b2\u2013arrestin\u20131. Mol. Med. Rep. 22 (6), 4499\u20134508 (2020).","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"85737_CR38","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.canlet.2016.02.043","volume":"375","author":"JS Chen","year":"2016","unstructured":"Chen, J. S. et al. MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK\/AKT signaling in hepatocellular carcinoma. Cancer Lett. 375 (1), 73\u201383 (2016).","journal-title":"Cancer Lett."}],"updated-by":[{"DOI":"10.1038\/s41598-025-13503-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85737-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85737-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85737-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T17:03:25Z","timestamp":1757264605000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85737-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,8]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["85737"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-85737-1","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41598-025-13503-4","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,8]]},"assertion":[{"value":"1 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-025-13503-4","URL":"https:\/\/doi.org\/10.1038\/s41598-025-13503-4","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All experiments with HCC tissues were approved by The Second Affiliated Hospital of Nanchang University Medical Research Ethics Committee, and the written informed consent was provided from each patient in accordance with the Helsinki Declaration. All animal experiments were approved by the Institutional Animal Care and Use Committee of Nanchang Royo Biotech Co,. Ltd. This study is conducted in accordance with ARRIVE guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Consent for publication has been obtained from the patients.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"1309"}}